June 22, 2022 — Recommendations on how to use gene testing to prevent sudden cardiac death in athletes and enable safe exercise are published in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).1
June 22, 2022 — Dr. Thomas Forbes, an interventional cardiologist, has joined Joe DiMaggio Children’s Hospital as its chief of pediatric cardiac services. Forbes, previously at Detroit Medical Center in Michigan, is leading an expanding roster of cardiac specialists as the Hollywood-based children’s facility significantly increases its size and capabilities while it adds four floors to the existing hospital building.
June 21, 2022 — Renibus Therapeutics (“Renibus”), a clinical-stage biotech company focusing on the prevention and treatment of cardio-renal diseases, today announced that its leadclinical candidate, RBT-1, met the primary endpoint of increasing the expression of biomarkers of cytoprotective preconditioning in a pre-specified interim Phase 2 data analysis.
June 20, 2022— Marc Chatzky may not feel like a cardiac pioneer, but he is, at least in South Florida. The Deerfield Beach resident was the first to have a defective pulmonary valve replaced without open-heart surgery, instead using a minimally-invasive transcatheter procedure and the recently-approved Harmony™ valve.
June 20, 2022 — Clinical trials of new gel treatments for stroke should be delayed until technology used in the tests is improved, according to research led at the University of Strathclyde.
June 17, 2022 — A multidisciplinary team of robotics and electronic systems engineers working with cardiologists and materials scientists has developed a medical robotic apparatus that uses an external magnetic field to precisely and remotely control guidewires through tiny and tortuous blood vessels. The team, led by researchers at Daegu Gyeongbuk Institute of Science and Technology (DGIST), reported their results in the journal Advanced Healthcare Materials.
June 15, 2022 — Cardiawave SA, a deeptech medical device manufacturer that has developed Valvosoft, a revolutionary non-invasive medical device to treat aortic stenosis, the most prevalent heart valve disease in adults, today announced positive MRI scans b
June 15, 2022 — Seven finalists have been selected for the Best Abstract Award in cardiovascular computed tomography. Each finalist will present their research at the 2022 Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting, July 15 – 17 in Las Vegas. The SCCT Best Abstract Award, supported by the Cardiovascular Research Foundation of Southern California (CVRF of So.